Announcement • Aug 04
Kowa Co.,Ltd. to Report Q2, 2027 Results on Oct 15, 2026 Kowa Co.,Ltd. announced that they will report Q2, 2027 results on Oct 15, 2026 Reported Earnings • Jul 19
First quarter 2027 earnings released: EPS: JP¥46.69 (vs JP¥27.96 in 1Q 2026) First quarter 2027 results: EPS: JP¥46.69 (up from JP¥27.96 in 1Q 2026). Revenue: JP¥1.80b (up 2.0% from 1Q 2026). Net income: JP¥194.0m (up 67% from 1Q 2026). Profit margin: 11% (up from 6.6% in 1Q 2026). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 10% per year. Reported Earnings • Jun 03
Full year 2026 earnings released: EPS: JP¥103 (vs JP¥145 in FY 2025) Full year 2026 results: EPS: JP¥103 (down from JP¥145 in FY 2025). Revenue: JP¥6.39b (flat on FY 2025). Net income: JP¥427.0m (down 31% from FY 2025). Profit margin: 6.7% (down from 9.7% in FY 2025). Announcement • May 22
Kowa Co.,Ltd. to Report Q1, 2027 Results on Jul 15, 2026 Kowa Co.,Ltd. announced that they will report Q1, 2027 results on Jul 15, 2026 Board Change • May 20
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. 2 independent directors (4 non-independent directors). Independent Outside Director Hajime Shirasaka was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Apr 14
Kowa Co.,Ltd., Annual General Meeting, May 28, 2026 Kowa Co.,Ltd., Annual General Meeting, May 28, 2026. Announcement • Apr 07
Kowa Co.,Ltd. to Report Fiscal Year 2026 Results on Apr 14, 2026 Kowa Co.,Ltd. announced that they will report fiscal year 2026 results on Apr 14, 2026 Announcement • Nov 06
Kowa Co.,Ltd. to Report Q3, 2026 Results on Jan 14, 2026 Kowa Co.,Ltd. announced that they will report Q3, 2026 results on Jan 14, 2026 Announcement • Jul 26
Kowa Co.,Ltd. to Report Q2, 2026 Results on Oct 15, 2025 Kowa Co.,Ltd. announced that they will report Q2, 2026 results on Oct 15, 2025 Announcement • Apr 14
Kowa Co.,Ltd., Annual General Meeting, May 29, 2025 Kowa Co.,Ltd., Annual General Meeting, May 29, 2025. Announcement • Feb 22
Kowa Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 14, 2025 Kowa Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 14, 2025 Announcement • Dec 17
Kowa Co.,Ltd. (TSE:7807) announces an Equity Buyback for 130,000 shares, representing 3.04% for ¥125.19 million. Kowa Co.,Ltd. (TSE:7807) announces a share repurchase program. Under the program, the company will repurchase up to 130,000 shares, representing 3.04% of its issued share capital (excluding treasury stock), for a total purchase price of ¥125.19 million. The shares will be repurchased at a price of ¥963 per share. The purpose of the program is to enhance shareholder returns and improve capital efficiency, as well as to enable it to implement flexible capital policies that respond to changes in the business environment. Announcement • Nov 20
Kowa Co.,Ltd. to Report Q3, 2025 Results on Jan 14, 2025 Kowa Co.,Ltd. announced that they will report Q3, 2025 results on Jan 14, 2025 New Risk • Sep 16
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Market cap is less than US$100m (€27.4m market cap, or US$30.5m). Announcement • Aug 20
Kowa Co.,Ltd. (TSE:7807) announces an Equity Buyback for 130,000 shares, representing 3.03% for ¥150 million. Kowa Co.,Ltd. (TSE:7807) announces a share repurchase program. Under the program, the company will repurchase up to 130,000 shares, representing 3.03% of its issued share capital (excluding treasury stock), for a total purchase price of ¥150 million. The purpose of the program is to enable the implementation of a flexible capital policy in response to changes in the business environment. The program will be valid till February 28, 2025. As of July 31, 2024, the company has 4,285,156 issued shares (excluding treasury stock) and 725,334 treasury shares. New Risk • Aug 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (€24.8m market cap, or US$27.1m). Valuation Update With 7 Day Price Move • Aug 06
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to €5.20, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 25x in the Medical Equipment industry in Germany. Total loss to shareholders of 12% over the past year. Announcement • Jul 31
Kowa Co.,Ltd. to Report Q2, 2025 Results on Oct 11, 2024 Kowa Co.,Ltd. announced that they will report Q2, 2025 results on Oct 11, 2024 Valuation Update With 7 Day Price Move • Jul 19
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to €6.25, the stock trades at a trailing P/E ratio of 6.5x. Average trailing P/E is 26x in the Medical Equipment industry in Germany. Total returns to shareholders of 2.3% over the past year. Reported Earnings • Jul 16
First quarter 2025 earnings released: EPS: JP¥52.61 (vs JP¥43.48 in 1Q 2024) First quarter 2025 results: EPS: JP¥52.61 (up from JP¥43.48 in 1Q 2024). Revenue: JP¥1.73b (flat on 1Q 2024). Net income: JP¥225.0m (up 7.7% from 1Q 2024). Profit margin: 13% (up from 12% in 1Q 2024). Reported Earnings • Jun 02
Full year 2024 earnings released: EPS: JP¥155 (vs JP¥88.51 in FY 2023) Full year 2024 results: EPS: JP¥155 (up from JP¥88.51 in FY 2023). Revenue: JP¥6.40b (up 2.2% from FY 2023). Net income: JP¥710.0m (up 62% from FY 2023). Profit margin: 11% (up from 7.0% in FY 2023). The increase in margin was primarily driven by lower expenses. Announcement • May 26
Kowa Co.,Ltd. to Report Q1, 2025 Results on Jul 12, 2024 Kowa Co.,Ltd. announced that they will report Q1, 2025 results on Jul 12, 2024 Announcement • Apr 15
Kowa Co.,Ltd., Annual General Meeting, May 29, 2024 Kowa Co.,Ltd., Annual General Meeting, May 29, 2024. Reported Earnings • Apr 14
Full year 2024 earnings released: EPS: JP¥155 (vs JP¥88.51 in FY 2023) Full year 2024 results: EPS: JP¥155 (up from JP¥88.51 in FY 2023). Revenue: JP¥6.40b (up 2.2% from FY 2023). Net income: JP¥710.0m (up 62% from FY 2023). Profit margin: 11% (up from 7.0% in FY 2023). The increase in margin was primarily driven by lower expenses. Buy Or Sell Opportunity • Apr 12
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 11% to €8.00. The fair value is estimated to be €10.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.5% over the last 3 years. Earnings per share has grown by 14%. Announcement • Feb 28
Kowa Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 12, 2024 Kowa Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 12, 2024 Valuation Update With 7 Day Price Move • Jan 19
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to €7.40, the stock trades at a trailing P/E ratio of 9.4x. Average trailing P/E is 31x in the Medical Equipment industry in Germany. Buying Opportunity • Jan 16
Now 27% undervalued after recent price drop Over the last 90 days, the stock is down 1.9%. The fair value is estimated to be €10.84, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.5% over the last 3 years. Earnings per share has grown by 14%. Reported Earnings • Jan 15
Third quarter 2024 earnings released: EPS: JP¥23.23 (vs JP¥35.98 in 3Q 2023) Third quarter 2024 results: EPS: JP¥23.23 (down from JP¥35.98 in 3Q 2023). Revenue: JP¥1.61b (flat on 3Q 2023). Net income: JP¥105.0m (down 41% from 3Q 2023). Profit margin: 6.5% (down from 11% in 3Q 2023). Announcement • Nov 29
Kowa Co.,Ltd. to Report Q3, 2024 Results on Jan 12, 2024 Kowa Co.,Ltd. announced that they will report Q3, 2024 results on Jan 12, 2024 Valuation Update With 7 Day Price Move • Oct 24
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to €7.10, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 26x in the Medical Equipment industry in Germany. Announcement • Oct 15
Kowa Co.,Ltd. (TSE:7807) announces an Equity Buyback for 640,000 shares, representing 13.43% for ¥857.6 million. Kowa Co.,Ltd. (TSE:7807) announces a share repurchase program. Under the program, the company will repurchase up to 640,000 shares, representing 13.43% of its issued share capital (excluding treasury stock), for a total purchase price of ¥857.60 million. The shares will be repurchased at a price of ¥1,340 per share. The purpose of the program is to improve capital efficiency and implement agile capital policies in response to changes in the business environment. As of August 31, 2023, the company has 4,763,784 issued shares (excluding treasury stock) and 223,006 treasury shares. Reported Earnings • Oct 13
Second quarter 2024 earnings released: EPS: JP¥34.20 (vs JP¥10.03 in 2Q 2023) Second quarter 2024 results: EPS: JP¥34.20 (up from JP¥10.03 in 2Q 2023). Revenue: JP¥1.55b (up 4.1% from 2Q 2023). Net income: JP¥163.0m (up 226% from 2Q 2023). Profit margin: 11% (up from 3.4% in 2Q 2023). The increase in margin was primarily driven by higher revenue. Announcement • Aug 30
Kowa Co.,Ltd. to Report Q2, 2024 Results on Oct 13, 2023 Kowa Co.,Ltd. announced that they will report Q2, 2024 results on Oct 13, 2023